文献速递前列腺癌

保留Retzius间隙与传统机器人辅助腹腔镜前列腺癌根治术在控尿与性功能方面的比较:一项更新Meta分析

Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-10-25

该Meta分析比较保留Retzius间隙机器人辅助前列腺癌根治术(RS-RARP)与传统术式(C-RARP),按PRISMA指南开展,采用Review Manager 5.3与Stata SE 14.0分析。结果显示RS-RARP在术后即刻及1、3、6、12个月控尿恢复上均优于C-RARP,而性功能恢复率及手术时间、出血量、住院时间、切缘阳性率、并发症无显著差异。

要点

  • RS-RARP在术后即刻至12个月各时间点控尿恢复均显著优于C-RARP
  • 两组性功能恢复率无显著差异
  • 手术时间、出血量、住院时间、切缘阳性率及并发症无显著差异

核心结论

  • RS-RARP术后控尿恢复优于C-RARP,性功能恢复率、手术时间、出血量、住院时间、切缘阳性率及并发症无显著差异。

研究设计与样本

  • 按PRISMA指南开展的Meta分析,使用Review Manager 5.3与Stata SE 14.0,连续数据用均数差(MD)及95%CI描述,二分类数据用比值比(OR)及95%CI描述,P<0.05为有统计学意义。

主要发现

  • 术后即刻控尿恢复OR 0.40(95%CI 0.20-0.77,P=0.007)
  • 术后1个月控尿恢复OR 0.17(95%CI 0.10-0.29,P<0.00001)
  • 术后3个月控尿恢复OR 0.18(95%CI 0.09-0.36,P<0.00001)
  • 术后6个月控尿恢复OR 0.26(95%CI 0.15-0.46,P<0.00001)
  • 术后12个月控尿恢复OR 0.50(95%CI 0.28-0.89,P=0.02)

临床怎么用

  • 对控尿恢复要求较高的前列腺癌根治术患者,可优先考虑RS-RARP,但需结合术者经验与肿瘤学安全性综合决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTACT: BACKGROUND: Studies comparing C-RARP and RS-RARP have reported different results and the choice between the two operation methods remains controversia. METHODS: We present the meta-analysis on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. The meta-analysis was carried out using Review Manager 5.3 (Cochrane Collaboration, Oxford, United Kingdom) and Stata SE 14.0. The mean difference (MD) with 95% confidence intervals (CI) were used to describe the results of continuous data; odds ratio (OR) with 95% CI were used to describe dichotomous data. Statistical significance was set at P < 0.05. RESULTS: The meta-analysis revealed that RS-RARP had a statistically significant advantage in terms of continence recovery immediately after operation (OR: 0.40, 95% CI: 0.20-0.77; P = 0.007) (Fig. 2a), after 1 month (OR: 0.17, 95% CI: 0.10-0.29; P < 0.00001) (Fig. 2b), after 3 months (OR: 0.18, 95% CI: 0.09-0.36; P < 0.00001) (Fig. 2c), after 6 months (OR: 0.26, 95% CI: 0.15-0.46; P < 0.00001) (Fig. 2d) and after 12 months (OR: 0.50, 95% CI: 0.28-0.89; P = 0.02) (Fig. 2e). CONCLUSIONS: This meta-analysis found that RS-RARP had better postoperative continence recovery than C-RARP, while sexual function recovery rates were not significantly different. There were also no significant differences in operation time, intraoperative blood loss, length of stay, positive margin rate and complications.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Liu J, Zhang J, Yang Z, et al. Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis. Prostate Cancer Prostatic Dis. 2021. PMID: 34697432. doi:10.1038/s41391-021-00459-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。